Connect your AI

OMDA OMDA Common stock, capital shares reserved for future issuance

Common stock, capital shares reserved for future issuance at other companies

Tandem Diabetes CareTNDM

——

Other financials

Income statement

Revenue$78.0M+42.0%

Gross profit$48.7M+52.6%

Operating income-$4.8M+43.1%

Net income-$3.0M+68.6%

EPS (diluted)-$0.05+95.7%

Balance sheet

Cash & equivalents$211.8M+257%

Total debt$30.0M—

Total equity$234.1M+160%

Total assets$302.8M—

Cash flow

Operating cash flow-$11.8M+26.6%

CapEx$78.0K-75.2%

Free cash flow-$11.9M+27.5%

Valuation

Market cap$1.11B+23.8%

P/S3.9×-0.4×

Profitability

Gross margin66.3%+4.4pp

Operating margin-9.6%-4.0pp

Net margin-11.3%-4.6pp

FCF margin-40.8%—

Returns & leverage

Return on equity26.8%—

Debt / equity0.1×—

Current ratio3.9×—

Where this comes from

Reported directly by OMDA in its filing.

Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.

The official record: OMDA’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OMDA's common stock, capital shares reserved for future issuance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OMDA's common stock, capital shares reserved for future issuance?: OMDA (OMDA) reported common stock, capital shares reserved for future issuance of $19.66M in Q1 2026.